Clinical Trials Browser

INDUSTRY × Small Cell Lung Carcinoma × irinotecan sucrosofate × Clear all

NCT03088813 2025-02-19

RESILIENT

Phase 3 Completed

491 enrolled 24 charts

Small Cell Lung Carcinoma

NCT04727853 2024-07-10

Study of Irinotecan Liposome Injection as Second-line Regimen in Patients With Small Cell Lung Cancer (SCLC)

Phase 2 Completed

Small Cell Lung Carcinoma